Related Experiment Video
Updated: Mar 12, 2026

Isolation and Profiling of MicroRNA-containing Exosomes from Human Bile
Published on: June 13, 2016
Exosomes-mediate microRNAs transfer in breast cancer chemoresistance regulation
Juliana Carvalho Santos1, Marcelo Lima Ribeiro2, Luis Otávio Sarian1
1Women's Health Hospital "Prof Dr José Aristodemo Pinotti" (CAISM), State University of Campinas (UNICAMP) Campinas, SP, Brazil.
Abstract:
Breast cancer is the most common and fatal type of cancer in women worldwide due to the metastatic process and resistance to treatment. Despite advances in molecular knowledge, little is known regarding resistance to chemotherapy. One highlighted aspect is the DNA damage response (DDR) pathway that is activated upon genotoxic damage, controlling the cell cycle arrest or DNA repair activation. Recently, studies have showed that cancer stem cells (CSCs) could promote chemoresistance through DDR pathway. Furthermore, it is known that the epithelial-mesenchymal transition (EMT) can generate cells with CSCs characteristics and therefore regulate the chemoresistance process. The exosomes are microvesicles filled with RNAs, proteins and microRNAs (miRNAs) that can be released by many cell types, including tumor cells and CSCs. The exosomes content may be cell-to-cell transferable and it could control a wide range of pathways during tumor development and metastasis. A big challenge for modern medicine is to determine the reasons why patients do not respond to chemotherapy treatments and also guide the most appropriate therapy for each one. Considering that the CSCs are able to stimulate the formation of a more aggressive tumor phenotype with migration and metastasis ability, resistance to treatment and disease recurrence, as well as few studies capable to determine clearly the interaction of breast CSCs with its microenvironment, the present review summarize the possibility that exosomes-mediate miRNAs transfer and regulate chemoresistance in breast tumor cells and CSCs, to clarify the complexity of breast cancer progression and therapy.
Insights
Breast cancer stem cells (CSCs) may drive chemoresistance via DNA damage response (DDR) pathways. Exosomes mediate microRNA transfer, potentially regulating this resistance and impacting breast cancer progression and therapy.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Breast cancer remains a leading cause of cancer-related deaths globally, primarily due to metastasis and treatment resistance.
- Chemoresistance in breast cancer is poorly understood, with cancer stem cells (CSCs) emerging as key players.
- The DNA damage response (DDR) pathway and epithelial-mesenchymal transition (EMT) are implicated in CSC-mediated chemoresistance.
Approach:
- This review explores the role of exosomes in mediating microRNA (miRNA) transfer between breast tumor cells and CSCs.
- It examines how exosome-derived miRNAs might regulate the DDR pathway and influence chemoresistance.
- The review discusses the interaction between CSCs and their microenvironment in the context of therapeutic resistance.
Key Points:
- CSCs possess characteristics that promote aggressive tumor phenotypes, including migration, metastasis, and resistance to therapy.
- Exosomes, released by tumor cells and CSCs, carry various molecules including miRNAs that can be transferred to other cells.
- Exosome-mediated miRNA transfer is a potential mechanism by which CSCs influence chemoresistance in breast cancer.
Conclusions:
- Understanding exosome-mediated communication is crucial for deciphering breast cancer progression and therapeutic resistance.
- Targeting exosome pathways could offer novel strategies to overcome chemoresistance in breast cancer patients.
- Further research is needed to elucidate the specific miRNAs and pathways involved in exosome-mediated chemoresistance in breast cancer.
Related Concept Videos
MicroRNAs
MicroRNAs
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...

